E. Aubrey Thompson

13.8k citations

112 papers · 5.0k indexed · h-index 42

Molecular Biology top 2%
Oncology top 2%
Cancer Research top 1%
Immunology top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Alan P. Fields Brian M. Necela Edith A. Perez David Reisman Selina Glaros Yan W. Asmann Tien C. Ko Weidong Su
Topics: HER2/EGFR in Cancer Research (18 papers)Cancer Genomics and Diagnostics (14 papers)Cancer Immunotherapy and Biomarkers (14 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Nucleic Acids Research Journal of Biological Chemistry Nature Communications
Partner nations: United States Canada Finland

In The Last Decade

E. Aubrey Thompson

109 papers receiving 4.9k citations

Peers

Countries citing papers authored by E. Aubrey Thompson

Since Specialization

Citations

This map shows the geographic impact of E. Aubrey Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Aubrey Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Aubrey Thompson more than expected).

Fields of papers citing papers by E. Aubrey Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Aubrey Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Aubrey Thompson. The network helps show where E. Aubrey Thompson may publish in the future.

Co-authorship network of co-authors of E. Aubrey Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of E. Aubrey Thompson. A scholar is included among the top collaborators of E. Aubrey Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Aubrey Thompson. E. Aubrey Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer 2024 ·Nature Communications ·Ligia I. Bastea,Xiang Liu,(unknown),Veethika Pandey,Heike Döppler,Brandy Edenfield,Murli Krishna,Lizhi Zhang,E. Aubrey Thompson,Paul M. Grandgenett,Michael A. Hollingsworth,DeLisa Fairweather,Dahn L. Clemens,Peter Störz	2
2	Identification of gene regulatory networks associated with breast cancer patient survival using an interpretable deep neural network model 2024 ·Expert Systems with Applications ·Xue Wang,Vivekananda Sarangi,Daniel P. Wickland,Shaoyu Li,Chen Duan,E. Aubrey Thompson,Garrett Jenkinson,Yan W. Asmann	1
3	Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old 2022 ·Journal of Alzheimer s Disease ·Christian Lachner,Gregory S. Day,(unknown),Naomi Kouri,Nilüfer Ertekin‐Taner,Bradley F. Boeve,Sydney A. Labuzan,John A. Lucas,E. Aubrey Thompson,(unknown),Julia E. Crook,(unknown),Keith A. Josephs,Ronald C. Petersen,Dennis W. Dickson,R. Ross Reichard,Michelle M. Mielke,David S. Knopman,Neill R. Graff‐Radford,Melissa E. Murray	3
4	Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer 2021 ·Clinical Cancer Research ·Jodi M. Carter,Mei‐Yin C. Polley,Roberto A. Leon‐Ferre,Jason P. Sinnwell,Kevin J. Thompson,Xue Wang,(unknown),David Zahrieh,Jennifer M. Kachergus,Malvika Solanki,Judy C. Boughey,Minetta C. Liu,James N. Ingle,Krishna R. Kalari,Fergus J. Couch,E. Aubrey Thompson,Matthew P. Goetz	35
5	Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial 2020 ·Clinical Cancer Research ·Karama Asleh,Heather Ann Brauer,Amy Sullivan,Susanna Lauttia,Henrik Lindman,Torsten O. Nielsen,Heikki Joensuu,E. Aubrey Thompson,Saranya Chumsri	20
6	Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2+ breast cancer samples 2018 ·BMC Cancer ·George Vasmatzis,Xue Wang,James B. Smadbeck,Stephen J. Murphy,Katherine B. Geiersbach,Sarah H. Johnson,Athanasios Gaitatzes,Yan W. Asmann,Farhad Kosari,Mitesh J. Borad,Daniel Serie,Sarah A. McLaughlin,Jennifer M. Kachergus,Brian M. Necela,E. Aubrey Thompson	14
7	Effective Targeting of Estrogen Receptor–Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101 2015 ·Molecular Cancer Therapeutics ·Sahra Borgés,Edith A. Perez,E. Aubrey Thompson,Derek C. Radisky,Xochiquetzal J. Geiger,Peter Störz	51
8	The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831 2015 ·Breast Cancer Research ·Edith A. Perez,Frederick L. Baehner,Steven M. Butler,E. Aubrey Thompson,Amylou C. Dueck,Farid Jamshidian,Diana B. Cherbavaz,Carl Yoshizawa,Steven Shak,Peter A. Kaufman,Nancy E. Davidson,Julie R. Gralow,Yan W. Asmann,Karla V. Ballman	17
9	Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial 2015 ·Journal of Clinical Oncology ·Edith A. Perez,E. Aubrey Thompson,Karla V. Ballman,S. Keith Anderson,Yan W. Asmann,Krishna R. Kalari,Jeanette E. Eckel‐Passow,Amylou C. Dueck,Kathleen Tenner,Jin Jen,Jian-Bing Fan,Xochiquetzal J. Geiger,Ann E. McCullough,Beiyun Chen,Robert B. Jenkins,George W. Sledge,Eric P. Winer,Julie R. Gralow,Monica M. Reinholz	144
10	Impact of Library Preparation on Downstream Analysis and Interpretation of RNA-Seq Data: Comparison between Illumina PolyA and NuGEN Ovation Protocol 2013 ·PLoS ONE ·Zhifu Sun,Yan W. Asmann,Asha Nair,Yuji Zhang,Liguo Wang,Krishna R. Kalari,Aditya Bhagwate,Tiffany R. Baker,Jennifer M. Carr,Jean-Pierre A. Kocher,Edith A. Perez,E. Aubrey Thompson	18
11	Detection of Redundant Fusion Transcripts as Biomarkers or Disease-Specific Therapeutic Targets in Breast Cancer 2012 ·Cancer Research ·Yan W. Asmann,Brian M. Necela,Krishna R. Kalari,Asif Hossain,Tiffany R. Baker,Jennifer M. Carr,Caroline Davis,(unknown),Galen Hostetter,Xing Li,Sarah A. McLaughlin,Derek C. Radisky,Gary P. Schroth,Heather E. Cunliffe,Edith A. Perez,E. Aubrey Thompson	75
12	MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer 2011 ·Trends in Molecular Medicine ·Cathy Andorfer,Brian M. Necela,E. Aubrey Thompson,Edith A. Perez	168
13	A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines 2011 ·Nucleic Acids Research ·Yan W. Asmann,Asif Hossain,Brian M. Necela,Sumit Middha,Krishna R. Kalari,Zhifu Sun,High-Seng Chai,David Williamson,Derek C. Radisky,Gary P. Schroth,Jean‐Pierre Kocher,Edith A. Perez,E. Aubrey Thompson	80
14	Overexpression of Evi‐1 oncoprotein represses TGF‐β signaling in colorectal cancer 2011 ·Molecular Carcinogenesis ·Xiyun Deng,Yanna Cao,Yan Liu,Fazhi Li,(unknown),Srinivasan Rajaraman,Archibald S. Perkins,Alan P. Fields,Mark R. Hellmich,Courtney M. Townsend,E. Aubrey Thompson,Tien C. Ko	28
15	Differential Expression of MicroRNAs in Tumors from Chronically Inflamed or Genetic (APCMin/+) Models of Colon Cancer 2011 ·PLoS ONE ·Brian M. Necela,Jennifer M. Carr,Yan W. Asmann,E. Aubrey Thompson	64
16	Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway 2009 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·David Maldonado‐Pérez,Pamela Brown,Kevin Morgan,Robert P. Millar,E. Aubrey Thompson,Henry N. Jabbour	37
17	Atypical Protein Kinase Cι Expression and Aurothiomalate Sensitivity in Human Lung Cancer Cells 2008 ·Cancer Research ·Roderick P. Regala,E. Aubrey Thompson,Alan P. Fields	76
18	Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis 2004 ·Nature Cell Biology ·Andrew R. Conery,Yanna Cao,E. Aubrey Thompson,Courtney M. Townsend,Tien C. Ko,Kunxin Luo	338
19	Role of Cyclooxygenase 2 in Protein Kinase C βII-mediated Colon Carcinogenesis 2003 ·Journal of Biological Chemistry ·Wangsheng Yu,Nicole R. Murray,Capella Weems,Lu Chen,Huiping Guo,Richard T. Ethridge,Jeffrey D. Ceci,B. Mark Evers,E. Aubrey Thompson,Alan P. Fields	65
20	Linkage information and bias in the presence of interference 1988 ·Genetic Epidemiology ·D. Timothy Bishop,E. Aubrey Thompson,D. C. Rao	4

About E. Aubrey Thompson

E. Aubrey Thompson is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 112 papers that have together received 5.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Immunotherapy and Biomarkers (14 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.6k citations) and Molecular Biology (3.3k citations). E. Aubrey Thompson has collaborated with scholars based in United States, Canada and Finland. Frequent co-authors include Alan P. Fields, Brian M. Necela, Edith A. Perez, David Reisman, Selina Glaros, Yan W. Asmann, Tien C. Ko, Weidong Su, Nicole R. Murray and Lee Jamieson. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact